scispace - formally typeset
K

Karin Jurkat-Rott

Researcher at University of Ulm

Publications -  145
Citations -  7129

Karin Jurkat-Rott is an academic researcher from University of Ulm. The author has contributed to research in topics: Skeletal muscle & Myotonia. The author has an hindex of 47, co-authored 143 publications receiving 6635 citations. Previous affiliations of Karin Jurkat-Rott include German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Voltage-Gated Ion Channels and Hereditary Disease

TL;DR: Unique among reviews of this topic is that all known human hereditary diseases of voltage-gated ion channels are described covering various fields of medicine such as neurology, nephrology, and cardiology, with interesting parallels in mechanisms of disease emphasized.
Journal ArticleDOI

Genetics and pathogenesis of malignant hyperthermia.

TL;DR: As a result of extensive research on the mechanisms of excitation‐contraction coupling and recent functional characterization of several disease‐causing mutations in heterologous expression systems, much is known about the molecular etiology of MH.
Journal ArticleDOI

Voltage-sensor Sodium Channel Mutations Cause Hypokalemic Periodic Paralysis Type 2 by Enhanced Inactivation and Reduced Current

TL;DR: The results prove that SCN4A, the gene encoding the sodium channel alpha subunit of skeletal muscle is responsible for HypoPP-2, a disease caused by enhanced channel inactivation and current reduction showing no myotonia.
Journal ArticleDOI

Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families

TL;DR: Performing a genome–wide search using polymorphic dinucleotide repeats, it is demonstrated that the gene encoding the muscle DHP–sensitive calcium channel α1 subunit (CACNL1A3) maps to the same region, sharing a 5 centiMorgan (cM) interval with the HypoPP locus.
Journal ArticleDOI

Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.

TL;DR: A complete penetrance in men and women, an early age at onset, postcritic myalgias and an increased number and severity of attacks induced by acetazolamide are observed in a large hypoPP family carrying an SCN4A mutation.